Investigation of the Impact of Foretinib on AURKA and AURKB Expression in T98 Glioblastoma Cell Line
Background: Gliomas are a common type of the primary brain tumors and account for more than 40% of all central nervous system (CNS) tumors. Glioblastoma (GBM) remains one of the most fatal human malignancies as it is highly angiogenic. Foretinib is an oral multikinase inhibitor that has been shown t...
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Mazandaran University of Medical Sciences and Health Services
2019-02-01
|
| Edice: | Research in Molecular Medicine |
| Témata: | |
| On-line přístup: | http://rmm.mazums.ac.ir/article-1-306-en.html |